US$ 26.61
tirzepatide solubility CAS 2023788-19-2 (Tirzepatide) Tirzepatide sodium | LY3298176 |
Description
Goals differ

More importantly, the PSR-MNs have the potential to serve as a platform for long-term delivery of other peptides, either alone, in combinations, or small molecules in general

Additionally, there are limitations in current clinical trial endpoints, like categorical fibrosis staging in assessing treatment effectiveness

10.1210/en.2008-0336 113

Get your meds Get your medication delivered straight to you 1
